Mycobacterium Avium Complex Pulmonary Disease
📧 Sign up to get email alerts when something new happens for Mycobacterium Avium Complex Pulmonary Disease.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2025-12-05FDA Approved: ARIKAYCE — Supplemental Application (Insmed Incorporated)
FDA approved a supplemental application for ARIKAYCE (amikacin liposome inhalation suspension) submitted by Insmed, expanding its label for …
-
CLINICAL_TRIALS trial_result · 2025-10-09Clinical Trial Update: A Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacokinetics of SPR720 as Compared With Placebo for the Treatment of Participants With Mycobacterium Avium Complex (MAC) Pulmonary Disease [Phase 2]
Phase 2 study evaluating SPR720 versus placebo for Nontuberculous Mycobacterial Pulmonary Disease, including MAC pulmonary disease, assessin…
-
CLINICAL_TRIALS research · 2025-10-09Clinical Trial Update: Short-term Antibiotic Therapy in Mycobacterium Avium Complex Pulmonary Disease [Phase 4]
A Phase 4 clinical trial is recruiting to evaluate short-term antibiotic therapy for Mycobacterium avium complex pulmonary disease.
-
CLINICAL_TRIALS trial_result · 2025-09-18Clinical Trial Update: Short-term Bactericidal Effect of Contezolid in MAC-PD [Phase 4]
Phase 4 clinical trial evaluating the short-term bactericidal effect of contezolid in Mycobacterium Avium Complex Pulmonary Disease; the stu…
-
CLINICAL_TRIALS research · 2025-09-15Clinical Trial Update: Prevention of Recurrence With Cordyceps Sinensis in Mycobacterium Avium Complex Pulmonary Disease [Phase 4]
A Phase 4 clinical trial is evaluating whether Cordyceps Sinensis can prevent recurrence in patients with Mycobacterium avium complex pulmon…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2025-06-29Clinical Trial Update: Pharmacokinetic Study of Minocycline in Patients With Pulmonary Nontuberculous Mycobacterial Disease [Phase 2]
Phase 2 pharmacokinetic study of minocycline in patients with Mycobacterium avium complex pulmonary disease has been terminated.
-
CLINICAL_TRIALS research · 2025-06-26Clinical Trial Update: A Prospective, Multicenter, Single-arm MAC-PD Cohort: a NTM-NET and ESGMYC Collaborative Study
A prospective, multicenter, single-arm study in Mycobacterium avium complex pulmonary disease is currently recruiting, sponsored by Radboud …
-
CLINICAL_TRIALS research · 2025-06-26Clinical Trial Update: Hypertonic Saline Inhalation for Mycobacterium Avium Complex Pulmonary Disease [Phase 4]
Phase 4 clinical trial updating recruitment for hypertonic saline inhalation to treat Mycobacterium avium complex lung disease, currently re…
-
FDA approval · 2020-10-19FDA Approved: ARIKAYCE — Supplemental Application (Insmed Incorporated)
The FDA approved a supplemental application for ARIKAYCE (amikacin liposome inhalation suspension) from Insmed Incorporated. The action upda…
-
CLINICAL_TRIALS trial_result · 2015-03-25Clinical Trial Update: Phase II Study of Amithiozone (Thiacetazone) for Patients With Mycobacterium Avium Complex Pulmonary Disease [Phase 2]
Phase II study of Amithiozone (Thiacetazone) for Mycobacterium avium complex pulmonary disease has completed.
-
CLINICAL_TRIALS withdrawal · 2013-04-04Clinical Trial Update: Improving Tolerance of Treatment of Pulmonary MAC Infections [Phase 2]
The Phase 2 trial aimed at improving tolerance of treatment for pulmonary Mycobacterium avium complex infections has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2007-11-01Clinical Trial Update: Safety and Efficacy of Inhaled Interferon Gamma-1b in Pulmonary MAC Infection [Phase 2]
Phase 2 trial evaluating inhaled Interferon gamma-1b for pulmonary Mycobacterium avium complex infection was terminated.